<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="679">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01049555</url>
  </required_header>
  <id_info>
    <org_study_id>09-PP-06</org_study_id>
    <nct_id>NCT01049555</nct_id>
  </id_info>
  <brief_title>Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research</brief_title>
  <acronym>09-PP-06</acronym>
  <official_title>Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neuropsychiatric symptoms form part of the clinical picture of Alzheimer's disease (AD) and&#xD;
      other dementias. Irrespective of the severity of the disease, the most frequently encountered&#xD;
      symptom is apathy. Apathy is increasingly diagnosed in patients with neurological and&#xD;
      psychiatric conditions. Apathy is a disorder of motivation, defined as &quot;the direction,&#xD;
      intensity and persistence of goal-directed behaviour&quot;. Most of the current descriptions&#xD;
      acknowledge this point and consider apathy in terms of a lack of goal-directed behaviour,&#xD;
      cognition or emotion. The classical neuropsychiatric symptom assessments are subjective&#xD;
      structured interview-based, using input from the caregiver and/or the patient. New&#xD;
      technologies are likely to provide us with a more objective measure. An example is ambulatory&#xD;
      actigraphy, consisting of a piezoelectric accelerometer designed to record arm movement in&#xD;
      three dimensions.&#xD;
&#xD;
      The aim of the present study is to assess using actigraphy and video recording signal, AD&#xD;
      patients with (n = 15) and without (n = 15) apathy and control subjects (n = 5) during an&#xD;
      activity of daily living scenario .&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>assessment of motricity</measure>
    <time_frame>one time point - at the only visit of protocol</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>video recording</measure>
    <time_frame>one time point - at the only visit of the protocol</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Alzheimer's Disease</condition>
  <arm_group>
    <arm_group_label>Alzheimer and apathy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Alzheimer's disease patients with apathy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>alzheimer without disease</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Alzheimer's disease patients without apathy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Case control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>subject without apathy neither Alzheimer's disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Actigraphy and video recording signal</intervention_name>
    <description>Actigraphy and video recording signal during 1 hour</description>
    <arm_group_label>Alzheimer and apathy</arm_group_label>
    <arm_group_label>Case control</arm_group_label>
    <arm_group_label>alzheimer without disease</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  male or female, &gt; 65 years ;&#xD;
&#xD;
          -  Alzheimer's disease according to the NINCDS-ADRDA criteria (McKhann,Drachman et al.&#xD;
             1984) ;&#xD;
&#xD;
          -  Mini Mental Test Examination (MMSE) &gt; 20 ;&#xD;
&#xD;
          -  no motor anomaly according to UPDRS III (tremblements, rigidit√© musculaire) ;&#xD;
&#xD;
          -  no depression criteria according to DSM IV-R criteria ;&#xD;
&#xD;
          -  patient with a cholinergic treatment at dose stable since 3 months ;&#xD;
&#xD;
          -  patient with social insurance ;&#xD;
&#xD;
          -  signature of informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  neuropsychologics assessment impossible due to sensorial and disrupt ;&#xD;
&#xD;
          -  prescription of psychotrop treatment (hypnotic, anxiolytic, antidepressant,&#xD;
             antipsychotic) in the week previous actigraphy recording.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe ROBERT, PU-PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nice University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nice University Hospital</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <study_first_submitted>January 12, 2010</study_first_submitted>
  <study_first_submitted_qc>January 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2010</study_first_posted>
  <last_update_submitted>September 29, 2015</last_update_submitted>
  <last_update_submitted_qc>September 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>alzheimer</keyword>
  <keyword>apathy</keyword>
  <keyword>actigraphy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

